- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| RHYTHM BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| Di | RHYTHM BIOSCIENCES LIMITED: Investor Presentation | - | ASX | ||
| 17.11. | RHYTHM BIOSCIENCES LIMITED: FY2025 R&D Tax Incentive Received & Loan Repayment | - | ASX | ||
| 05.11. | RHYTHM BIOSCIENCES LIMITED: Final Director's Interest Notice - Otto Buttula | 1 | ASX | ||
| 05.11. | RHYTHM BIOSCIENCES LIMITED: Results of Meeting | - | ASX | ||
| 05.11. | RHYTHM BIOSCIENCES LIMITED: Gavin Fox-Smith appointed Chair of Rhythm Biosciences | - | ASX | ||
| 04.11. | RHYTHM BIOSCIENCES LIMITED: Post-AGM Investor Presentation | - | ASX | ||
| 29.10. | RHYTHM BIOSCIENCES LIMITED: ColoSTAT Clinical performance update | - | ASX | ||
| 28.10. | RHYTHM BIOSCIENCES LIMITED: Appendix 4C and Market Update | - | ASX | ||
| 10.10. | RHYTHM BIOSCIENCES LIMITED: Investor Presentation | - | ASX | ||
| 07.10. | RHYTHM BIOSCIENCES LIMITED: Notice of Annual General Meeting/Proxy Form | 1 | ASX | ||
| 29.09. | RHYTHM BIOSCIENCES LIMITED: Appendix 4G & Corporate Governance Statement | - | ASX | ||
| 29.09. | RHYTHM BIOSCIENCES LIMITED: RHY FY2025 Annual Report | - | ASX | ||
| 18.09. | RHYTHM BIOSCIENCES LIMITED: Cleansing Notice | - | ASX | ||
| 18.09. | RHYTHM BIOSCIENCES LIMITED: Application for quotation of securities - RHY | - | ASX | ||
| 17.09. | RHYTHM BIOSCIENCES LIMITED: Proposed issue of securities - RHY | - | ASX | ||
| 09.09. | RHYTHM BIOSCIENCES LIMITED: AGM date and closing date for director nominations | 1 | ASX | ||
| 29.08. | RHYTHM BIOSCIENCES LIMITED: RHY Financial Report FY2025 | - | ASX | ||
| 29.08. | RHYTHM BIOSCIENCES LIMITED: Appendix 4E | - | ASX | ||
| 28.08. | RHYTHM BIOSCIENCES LIMITED: Strategic partnership with Know Your Lemons Foundation | - | ASX | ||
| 27.08. | RHYTHM BIOSCIENCES LIMITED: Change in substantial holding - Otto Buttula | - | ASX |
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GENEDX | 167,52 | 0,00 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| PROGYNY | 26,770 | 0,00 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| ALIGNMENT HEALTHCARE | 19,150 | 0,00 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| CASTLE BIOSCIENCES | 39,930 | 0,00 % | Castle Biosciences: Starke Wachstumsdynamik und erhöhte Umsatzprognose | ||
| PRIVIA HEALTH GROUP | 24,560 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,270 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 36,210 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ADAPTHEALTH | 9,680 | -1,83 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| SIEMENS HEALTHINEERS | 42,440 | -0,21 % | BARCLAYS stuft Siemens Healthineers auf 'Positiv' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Siemens Healthineers von 61,00 auf 61,50 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktienkurse... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,630 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,310 | -0,86 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 51 auf 48 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Die Aktienkurse der europäischen... ► Artikel lesen | |
| PACS GROUP | 31,820 | 0,00 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BILLIONTOONE | 129,90 | 0,00 % | BillionToOne, Inc.: BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced... ► Artikel lesen | |
| NUTEX HEALTH | 119,20 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports September 30, 2025 Third Quarter And Year-to-date Financial Results | Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%
Net... ► Artikel lesen | |
| FRESENIUS | 47,330 | -0,69 % | Fresenius SE wackelt - dieser Boden sollte halten | Die Fresenius SE-Aktie steht kurz vor einer wichtigen Unterstützung. Hält der Bereich, oder droht ein Rückfall in tiefere Kursregionen Den vollständigen Artikel lesen ... ► Artikel lesen |
Das Unternehmen RHYTHM BIOSCIENCES LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,003 (-5,26 %) liegt der Kurs bei 0,045 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RHYTHM BIOSCIENCES LIMITED finden Sie auf Wallstreet Online.